Low-grade endometrial stromal sarcoma treated with the aromatase inhibitor letrozole
- 1 December 2004
- journal article
- case report
- Published by Elsevier in Gynecologic Oncology
- Vol. 95 (3) , 769-771
- https://doi.org/10.1016/j.ygyno.2004.07.063
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Long-Term Survival of Patients Given Hormonal Therapy for Metastatic Endometrial Stromal SarcomaMedical Oncology, 2003
- Endometrial Stromal Sarcoma: Objective Response to LetrozoleGynecologic Oncology, 2001
- Letrozole, a new oral aromatase inhibitor for advanced breast cancer: double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetate.Journal of Clinical Oncology, 1998
- Steroid Hormone Receptors in Endometrial Stromal Sarcomas: A Biochemical and Immunohistochemical StudyAmerican Journal of Clinical Pathology, 1992
- Endometrial stromal sarcomasGynecologic Oncology, 1990
- Endolymphatic stromal myosis. Surgical and hormonal treatment of extensive abdominal recurrence 20 years after hysterectomyCancer, 1982